about
CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-kappa B activationB cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5Identification of CCR8, the receptor for the human CC chemokine I-309Recruitment of TNF receptor 1 to lipid rafts is essential for TNFalpha-mediated NF-kappaB activation.Differential insertion of GPI-anchored GFPs into lipid rafts of live cells.Prostaglandin E2 is generally required for human dendritic cell migration and exerts its effect via EP2 and EP4 receptors.Prostaglandin E2 at new glance: novel insights in functional diversity offer therapeutic chances.Epithelial chemokine CXCL14 synergizes with CXCL12 via allosteric modulation of CXCR4.TYMSTR, a putative chemokine receptor selectively expressed in activated T cells, exhibits HIV-1 coreceptor function.CCR7: roles in cancer cell dissemination, migration and metastasis formation.In vivo TCR Signaling in CD4(+) T Cells Imprints a Cell-Intrinsic, Transient Low-Motility Pattern Independent of Chemokine Receptor Expression Levels, or Microtubular Network, Integrin, and Protein Kinase C Activity.Loss of Gadkin Affects Dendritic Cell Migration In VitroCommon and biased signaling pathways of the chemokine receptor CCR7 elicited by its ligands CCL19 and CCL21 in leukocytes.Inflammation-Induced CCR7 Oligomers Form Scaffolds to Integrate Distinct Signaling Pathways for Efficient Cell Migration.Distinct CCR7 glycosylation pattern shapes receptor signaling and endocytosis to modulate chemotactic responses.A novel cytosolic class I antigen-processing pathway for endoplasmic-reticulum-targeted proteinsLoss of GM130 in breast cancer cells and its effects on cell migration, invasion and polarity.Modulation of Chemokine Receptor Function by Cholesterol: New Prospects for Pharmacological Intervention.Chemokines: Chemistry, Biochemistry and Biological Function.On the move: endocytic trafficking in cell migration.Regulation of Sec16 levels and dynamics links proliferation and secretion.Definition of key variables for the induction of optimal NY-ESO-1-specific T cells in HLA transgene mice.Increased mobility of major histocompatibility complex I-peptide complexes decreases the sensitivity of antigen recognitionV domain of RAGE interacts with AGEs on prostate carcinoma cells.Opposite fate of endocytosed CCR7 and its ligands: recycling versus degradation.Posttranscriptional regulation of Fas (CD95) ligand killing activity by lipid rafts.The beta1 and beta3 integrins promote T cell receptor-mediated cytotoxic T lymphocyte activation.Expression of high- and low-affinity receptors for C3a on the human mast cell line, HMC-1.Soluble major histocompatibility complex-peptide octamers with impaired CD8 binding selectively induce Fas-dependent apoptosis.Interstitial dendritic cell guidance by haptotactic chemokine gradients.A structure-activity relationship linking non-planar PCBs to functional deficits of neural crest cells: new roles for connexins.New insights in chemokine signaling.Membrane lipid environment: Potential modulation of chemokine receptor function.Analysis of CCR7 mediated T cell transfectant migration using a microfluidic gradient generator.Chemokine axes in breast cancer: factors of the tumor microenvironment reshape the CCR7-driven metastatic spread of luminal-A breast tumors.A unique signal sequence of the chemokine receptor CCR7 promotes package into COPII vesicles for efficient receptor trafficking.Prostaglandin E2 is a key factor for monocyte-derived dendritic cell maturation: enhanced T cell stimulatory capacity despite IDOCCL19 with CCL21-tail displays enhanced glycosaminoglycan binding with retained chemotactic potency in dendritic cellsZAP70 expression enhances chemokine-driven chronic lymphocytic leukemia cell migration and arrest by valency regulation of integrinsFluorescently Tagged CCL19 and CCL21 to Monitor CCR7 and ACKR4 Functions
P50
Q24303589-EC79BA33-19D1-43D8-A54D-5BB41D08F3B1Q24309316-789E2A7D-6C9F-47D1-AE7C-09713861B219Q28242942-E06D56FD-6C47-46FE-AF3F-5B4025FBDB93Q33187061-2E4F1215-0836-4D26-8C0E-076A770C47E4Q33208515-848F8EE3-79EA-4D26-97BD-CA6808FA6114Q33230925-9B06DDF1-7F24-4B32-87EF-6446C62B163FQ33507471-DC7ED12A-0936-4653-AD49-24EE29FB0847Q33803636-86E8BF75-9903-4919-88C9-BF4E151E55CFQ34438029-2D206C45-F31A-4050-B6EC-AAB3CD0DC174Q35206292-55D02278-92B1-439B-AE6F-8F85987D78B4Q35693174-96BE61A8-DF26-4BC1-ABB3-FBC6FF3406E7Q35856882-691E08E5-339A-4F17-9C49-0DDAD492610FQ35884888-295470F1-96DD-4971-A8D9-EA400FB8C192Q35899048-4EC1BDB8-AA46-47DB-B6AA-9524E790EF5CQ35906663-8F0BABC4-2017-479C-B045-BB86B7314413Q36029951-7245BCC5-A11C-4EB7-9A7E-BB608CCA277DQ36182233-0BD8A90A-8860-4409-ADBA-BEE8E9AE7207Q36248192-7AC4FE44-1217-4F71-AD67-F6064285FDC2Q36414067-9BDD1A67-6513-4365-923D-8F433ABF7EC2Q38355587-FA9FFC49-8F12-4EE4-B465-7C4650BCE1B6Q38926875-C7DC76CA-B70A-434D-B1D7-BAF4C44BC630Q39664149-5450535D-4F6D-4983-852F-F51A347D8C15Q39968278-9FE2F369-B441-43C0-AF1A-B03F87DCEF6CQ40008758-EA660C48-A8A9-4BAC-A385-E5921CCADD47Q40247880-18A3F9F0-7992-42B1-9EF4-1D500DBA414EQ40342735-80F5BAFC-53D5-49CB-8BAC-FE7FD396AE82Q40656302-B2C841AA-15AD-4367-AA6B-FBD04963529DQ41211064-27D49B86-671F-4E23-9A3E-592D5FAC5FDBQ44198656-26DA7AE9-5711-4D7C-8402-5BFCDEDFA5ADQ44994477-A6649ED4-171A-473F-AE0C-2282BCD235E1Q47375329-6C933E67-30D5-4CB0-AC93-5643C9ECA46EQ50054649-66ADEB4F-1641-4818-9499-A402428EA190Q50056742-CA4FB11E-1489-4879-AC40-AA03F750D0DBQ50438530-FE1D10CC-DA8A-4470-AB52-E19730851D6EQ51472977-57DBD40A-54E6-40C9-8F98-5E5B2CA54258Q52722765-732B11D3-A5D5-4270-A9CB-58F9438B837FQ57896753-051AE3F1-DF07-4D88-AD7E-0316C40D1D0AQ59166566-1CEE77CC-C305-488D-B25C-13151693C297Q59881443-C3FC6CAE-C053-4591-9E0E-C85DB7AD91D0Q60919602-60FD8EB1-6E7C-48BC-BA9B-0817A4B83340
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Daniel F Legler
@ast
Daniel F Legler
@en
Daniel F Legler
@es
Daniel F Legler
@nl
Daniel F Legler
@sl
type
label
Daniel F Legler
@ast
Daniel F Legler
@en
Daniel F Legler
@es
Daniel F Legler
@nl
Daniel F Legler
@sl
prefLabel
Daniel F Legler
@ast
Daniel F Legler
@en
Daniel F Legler
@es
Daniel F Legler
@nl
Daniel F Legler
@sl
P106
P21
P31
P496
0000-0001-8610-4764